Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
AlphaRx signed a long-term contract manufacturing...
Pharmaron Holdings Limited has completed its acquisition...
OrbusNeich has enrolled the first patient in a China...
WuXi PharmaTech (药明康德), continuing the string of...
Venturepharm Laboratory said it signed a letter of intent...
The spectacular IPO of Sinopharm Group in September 2009...
WuXi PharmaTech reported impressive Q3 results, showing...
Novo Nordisk will spend up to $100 million to expand its...
PPD, Inc. announced a joint venture that will extend the...
Xu Tian, PhD, is an accomplished China transplant with...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
